Obtain accurate genotyping results quickly with One Lambda SmartType, a real-time PCR-based assay. This assay provides both a high degree of selectivity through target-specific amplification and broad DNA allele coverage capabilities of up to three target measurements per well.
LABScreen Single Antigen kits are effective tools for detecting HLA antibodies, both pre- and post-transplantation. Now with our expanded coverage kits you have the power to develop even more complete antibody profiles for your patients.
The LABScreen Multi is the first FDA cleared antibody screening assay for the detection of HLA Class I, Class II, HNA 1, 2, 3, 4, and 5. This bead based assay is capable of high throughput processing...
One Lambda has developed a next generation sequencing (NGS) solution for your HLA typing workflow! The NXType sequencing assay, together with the proven technology of the Ion Torrent Personal Genome Machine (PGM), enables first pass, high-resolution genotyping of the Class I and Class II loci...
Register for our upcoming webinar where Dr. Annette Jackson, of John Hopkins Univeristy, will discuss transplant methods, risk factors, limitations, and antibody monitoring.
CANOGA PARK, Calif.--(BUSINESS WIRE)--One Lambda, Inc., part of Thermo Fisher Scientific and leading producer of in vitro diagnostic products for the HLA transplant community, today announced the availability of the only FDA cleared and CE marked assay for detecting HNA-3, as well as HLA...
One Lambda, Inc. and GenoDive Pharma, Inc. Enter Exclusivity Agreement on Long-Range Primers for NGS
CANOGA PARK, Calif.--(BUSINESS WIRE)--One Lambda, Inc., part of Thermo Fisher Scientific, announced it has entered into an agreement with Japan-based GenoDive Pharma, Inc. for exclusive rights to their long-range primers and amplification conditions for human leukocyte antigen (HLA) locus-specific amplification. The agreement covers GenoDive’s primers and conditions for HLA A, B, C, DRB1, DRB345, DQA1, DQB1, DPA1 & DPB1 loci.
One Lambda Announces the Availability of its New RUO NXType Kit, a Complete Solution for HLA Typing by NGS
CANOGA PARK, Calif.--(BUSINESS WIRE)--One Lambda, Inc., part of Thermo Fisher Scientific and leading producer of research and in vitro diagnostic products for the HLA transplant community, today launched its RUO NXType™ Kit, a research use only (RUO) solution for human leukocyte antigen (HLA) typing by next-generation sequencing (NGS). Last Updated: 2016.05.24 for trademark usage.
Newsletter | 2016.Q3Download Newsletter »
In This Issue:
- Bringing Real-Time PCR to the HLA Lab
- HLA Mismatched HSCT on the Rise: New Opportunities and New Barriers
- Communications Updates
- Upcoming Events, Tradeshows, and Workshops
Newsletter | 2016.Q1
In This Issue:
- Celebrating 30 Years of Education in HLA & Transplantation
- Product Updates
- New Product Releases
- Products in Development
- Going Green
Last Updated: 2016.05.24 (for trademark usage)